Purchase Order 75N91025P00430

Award Date 9/20/25
Potential Completion Date 9/19/26
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,000 firm fixed price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract has an ultimate completion date of July 4, 2026 and is not set aside. 10X Genomics specializes in single-cell and spatial genomic analysis solutions that support...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a biotechnology company that specializes in advanced genomic analysis platforms, reagents, instruments, and bioinformatics software. The contract, valued at $24,608.17, is for the delivery of 10X Genomics Kits to support biomedical research at the NIH. The contract does not have a set-aside designation. 10X Genomics has been awarded numerous federal...
This is a $19,248 firm fixed price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract, which has a completion date of January 24, 2026, does not have a set-aside designation. 10X Genomics is providing specialized scientific equipment,...
This firm fixed price purchase order contract was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH), to 10X Genomics, Inc. The $11,000.00 contract provides 10X Genomics' products and services for single-cell and spatial analysis applications to support biomedical research. This includes specialized kits, instruments such as the Chromium Controller and Visium Spatial Gene Expression system, as well as...
This is a $12,000 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a life sciences technology company headquartered in Pleasanton, California. The contract is not set aside and runs through July 2026. 10X Genomics will provide specialized scientific equipment, consumables, and research tools to support advanced biomedical research across various domains, including infectious diseases, cancer, neurological disorders, and...
This is a firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and research tools. The contract is for the procurement of Chromium Next GEM Single Cell ATAC Kits and Chromium Next GEM Chip H Single Cell Kits, with a ceiling value of $24,910.17 and a period of...
This firm fixed price purchase order was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to 10X Genomics, Inc., a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The $137,890.00 contract is for the supply of 10X Genomics' genomic analysis platforms, reagents, instruments, and bioinformatics software to enable high-throughput interrogation of biological systems at single cell...
This firm fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. for the acquisition of a Visium CytAssist system. The $75,395 contract has a period of performance through September 22, 2023 and does not utilize a set-aside designation. 10X Genomics, a for-profit manufacturer of life sciences technology products and services, has previously provided single-cell and spatial...
This firm fixed-price purchase order contract was awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. for $45,829.38. The contract is for the provision of 10X Genomics' Chromium Next GEM Single Cell Multiome ATAC + Gene Expression Reagent Bundle and related items to support single-cell RNA sequencing research at NIA. This requirement was set aside for small businesses. 10X...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health (NIH), to 10X Genomics, Inc. The contract, valued at $100,100.00, is for the provision of 10X Genomics' specialized genomics analysis products and services, including kits, instruments, and supporting services for single-cell and spatial analysis applications. The contract supports biomedical...

This is a firm fixed-price purchase order awarded by the National Cancer Institute, which is part of the National Institutes of Health (NIH), a civilian federal agency, to 10X Genomics, Inc., a manufacturer of genomic analysis platforms, reagents, and instruments. The contract is valued at $12,000.00 and has an ultimate completion date of September 19, 2026. The contract does not have a set-aside designation.

10X Genomics supplies specialized scientific equipment, consumables, and research tools to various NIH agencies, including the National Institute on Aging, National Institute of Allergy and Infectious Diseases, and National Institute of Neurological Disorders and Stroke, to support advanced biomedical research across domains such as infectious diseases, cancer, neurological disorders, and age-related conditions. This specific contract is likely for the provision of 10X Genomics' products, such as Chromium Next GEM Single Cell Kits, Visium Spatial Gene Expression systems, and Xenium Analyzers, to the National Cancer Institute to further its research initiatives.

Generated 7/15/25, 4:03 PM